Myneo oncology
WebmyNEO leads in genomic-informed target discovery in the field of immuno-oncology. The ImmunoEngine© is a computational sequencing-based … WebContact Information Website www.myneo.me Ownership Status Privately Held (backing) Financing Status Accelerator/Incubator Backed Primary Industry Biotechnology Other Industries Discovery Tools (Healthcare) Primary Office MeetDistrict 540, Ottergemsesteenweg Zuid 808 Bus B511 9000 Ghent Belgium Want detailed data on 3M+ …
Myneo oncology
Did you know?
WebAug 18, 2024 · And, as a signal of the increased investability of mRNA cancer vaccine technology, in May 2024, CureVac announced a partnership with bioinformatics-based immunotherapy business, myNeo, to help speed up its antigen-identifying process. WebThe my NEO technology The my NEO bioinformatic platform focuses on identifying, exploring and validating alterations leading to aberrant surface molecules. Tumour-unique …
WebMay 25, 2024 · - CureVac is broadening its foundation in oncology, leveraging recent progress with its second-generation mRNA backbone - The partnership combines CureVac's mRNA technology with myNEO's platform for the discovery and selection of tumor antigens predicted to elicit strong immune responses - Together with myNEO, CureVac aims to … WebFor the past years, myNEO has been developing the neoantigen prediction platform, providing a robust pipeline focused on the identification and prediction of neoantigens. Graphical representation of the basis of the my NEO ImmunoEngine wireframe. The process starts with the identification of all tumour somatic non-synonymous mutations (NSM).
WebMay 21, 2024 · “myNEO technology makes personalized immunotherapy available for every patient, including patients with relapsed tumors that do not respond to standard … WebThe primary therapeutic focus of myNEO’s patient-specific tumour screening platform is personalised immunotherapy through neoantigen ... It merges the field of oncology with immunology into immuno-oncology, an exciting path that has the potential to dramatically improve treatment efficacy and specificity. Although generic immunotherapy (e.g ...
WebMay 25, 2024 · CureVac is broadening its foundation in oncology, leveraging recent progress with its second-generation mRNA backboneThe partnership combines CureVac's mRNA technology with myNEO's platform for ...
WebNov 4, 2024 · Precision oncology company MyNeo has released a new version of its ImmunoEngine bioinformatics platform. The update incorporates two new machine-learning algorithms, NeoMS, a transformer-based predictor based on major histocompatibility complex (MHC) ligandomic data, and NeoIM, a random-forest classifier trained to classify … portsmouth non emergency police phone numberWebApr 7, 2024 · Within the collaboration, the Belgium-based companies will use their respective technologies —OncoDNA's whole-genome and whole-transcriptome sequencing capabilities, and myNEO's artificial intelligence and bioinformatics capabilities — to identify targetable neoantigens in individual cancer patients and design mRNA-based vaccines that instruct … oracel oneWebThe myNEO ImmunoEngine© is a sequencing-based computational neoepitope selection platform that predicts the most efficacious targets for each individual cancer patient, key … portsmouth night and day our ladiesWebDec 29, 2024 · The myNEO ImmunoEngine© is a sequencing-based computational neoepitope selection platform that predicts the most efficacious targets for each individual cancer patient, key to developing a successful personalized immunotherapy. oracene and richard williamsWebApr 7, 2024 · While OncoDNA will perform whole genome and whole transcriptome sequencing, myNEO will handle the advanced interpretation of the sequenced data and design the optimal vaccine construct for maximum clinical benefit. The project promises to guide patients through a completely personalized journey. oracet® orange 220WebMay 25, 2024 · myNEO is a Belgian biotech company that focuses on the development of immunotherapies finetuned against the tumour of cancer patients. The core technology to its clinical development is an advanced data analysis platform that allows to rapidly screen immuno-genomic datasets from enrolled patients and their tumours. orach enterprisesWeb27 vacatures voor Clinical Research in 9040 Gent op Indeed.com. Solliciteer op vacatures voor Clinical Assistant, Supply Manager, Junior Bioinformatician en ander werk. orach chayim